In data: US passes crypto bill as centralised crypto topped 2023 blockchain M&A activity
05/23/2024 16:51Around 3.7% of all technology M&A deals in 2023 were blockchain related.
The US House of Representatives passed a landmark bill on Wednesday (22 May) to regulate cryptocurrency in the country, as centralised crypto topped blockchain M&A activity in 2023.
The Financial Innovation and Technology for the 21st Century Act (FIT21) was passed by a 279-136 vote and will now be passed to the US Senate to enact.
The bill is intended to support the US crypto industry by providing legal clarity and protection for cryptocurrency users.
According to Republican Rep. Patrick McHenry, the bill will end the "food fight for control" of crypto between the Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission.
SEC Chair Gary Gensler has criticised the bill for creating regulatory gaps.
“[FIT21] would create new regulatory gaps and undermine decades of precedent regarding the oversight of investment contracts, putting investors and capital markets at immeasurable risk,” stated Gensler.
In its 2024 thematic intelligence report into blockchain technology, research and analysis company GlobalData recorded that blockchain was seeing an increase in the number of tech M&A deals related to the technology.
By 2023, around 3.7% of all technology M&A deals were related to blockchain technology, up from just 2.2% in 2020.
GlobalData reported that the primary targets of these deals were blockchain development platforms, mining and node infrastructure players, and crypto exchanges and trading platforms.
Large, centralised cryptocurrency exchange platforms such as Coinbase and Kraken led this M&A activity.
Between 2014 and 2023, the majority of these deals were based in the US. Around 35% of all blockchain M&A deals were conducted by US companies.
"In data: US passes crypto bill as centralised crypto topped 2023 blockchain M&A activity" was originally created and published by Verdict, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.